Arena Pharmaceuticals, Inc.’s (ARNA) share price has entered into oversold territory with a stochastic value of 2.1732. The Zacks Consensus Estimate on the company’s loss for year ending December 2012 decreased by 8 cents over the past two months to a loss of 30 cents per share. Arena Pharmaceuticals, Inc. is a Zacks #2 Rank (“Buy”) company.
More From Zacks.com
- Investment & Company Information